SELEC: Sulfur based linchpins for the selective coupling of electrophilic fragments

A single chemical trick could replace temperamental, hard-to-handle ingredients in drug manufacturing with stable, widely available alternatives. Pharmaceutical and agrochemical companies rely heavily on molecules made of two linked heterocycles—ring-shaped structures that are the workhorses of modern drug design. The standard way to build these is to couple a "nucleophilic" fragment (which donates electrons) with an "electrophilic" fragment (which accepts them). The problem is that the nucleophilic partner is often an organometallic reagent: reactive, air-sensitive, and difficult to make or store. This project proposes a workaround. Instead of forcing one fragment to act as a nucleophile, the researchers will use a sulfur-based "linchpin" molecule that allows two electrophilic fragments—such as commercially abundant heteroaryl halides—to be coupled directly. The linchpin forms a sulfinate intermediate in situ, then undergoes two sequential palladium- or palladium/copper-catalysed reactions to forge the final bond. If successful, this method (SELEC) would give chemists a practical, broad-scope tool to skip the problematic organometallic step. The immediate impact is on manufacturing efficiency: cheaper, more stable starting materials could streamline the synthesis of new drugs and crop-protection chemicals. This is fundamental synthetic chemistry—it does not treat a disease or fix a supply chain today—but it removes a bottleneck that quietly slows the development of many medicines people will take tomorrow.